[On the mechanism of action of a new antihypertensive substance with imidazoline structure].
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001919:Bradycardia / Q000139:chemically induced; D001949:Bretylium Compounds / Q000494:pharmacology; D002415:Cats; D003864:Depression, Chemical; D004558:Electric Stimulation; D006145:Guanethidine / Q000494:pharmacology; D006339:Heart Rate; D007001:Hypogastric Plexus / Q000502:physiology; D007022:Hypotension / Q000139:chemically induced; D007093:Imidazoles / Q000494:pharmacology*; D008297:Male; D008526:Medulla Oblongata / Q000502:physiology; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000502:physiology*; D014649:Vas Deferens / Q000502:physiology
D000959:Antihypertensive Agents; D001949:Bretylium Compounds; D007093:Imidazoles; D006145:Guanethidine
Uber den Wirkungsmechanismus einer neuen antihypertensiven Substanz mit Imidazolinstruktur.